Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty

American Heart Journal

Volumn 150, Issue 6, 2005, Pages 1185-1189

  De Luca, Giuseppe ^a   Suryapranata, Harry ^a   Ottervanger, Jan Paul ^a   Van't Hof, Arnoud W J ^a   Hoorntje, Jan C A ^a   Gosselink, A T Marcel ^a   Dambrink, Jan Henk E ^a   Zijlstra, Felix ^a   De Boer, Menko Jan ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CIRCADIAN RHYTHM; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; TIME; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; CIRCADIAN RHYTHM; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 28844478520     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.01.057     Document Type: Article

References (39)

1. T.J. Ryan, E.M. Antman, and N.H. Brooks 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial infarction) Circulation 100 1999 1016 1030
2. C.L. Grines, K.F. Browne, and J. Marco A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group N Engl J Med 328 1993 673 679
3. F. Zijlstra, J.C.A. Hoorntje, and M.J. de Boer Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction N Engl J Med 341 1999 1413 1419
4. H. Suryapranata, A. van 't Hof, and J.C.A. Hoorntje Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction Circulation 97 1998 2502 2505
5. G. Stone, C.L. Grines, and A.D. Cox Comparison of angioplasty with stenting with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
6. D. Antoniucci, A. Migliorini, and G. Parodi Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone Circulation 109 2004 1704 1706
7. J.E. Muller, P.H. Stone, and Z.G. Turi Circadian variation in the frequency of onset of acute myocardial infarction N Engl J Med 313 1985 1315 1322
8. T. Kono, H. Morita, and T. Nishina Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy J Am Coll Cardiol 27 1996 774 778
9. G.H. Tofler, J.E. Muller, and P.H. Stone Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group J Am Coll Cardiol 20 1992 1049 1055
10. J.E. Muller, G.H. Tofler, and P.H. Stone Circadian variation and triggers of onset of acute cardiovascular disease Circulation 79 1989 733 743
11. G.H. Tofler, D. Brezinski, and A.I. Schafer Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death N Engl J Med 316 1987 1514 1518
12. F. Andreotti, G.J. Davies, and D.R. Hackett Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke Am J Cardiol 62 1988 635 637
13. K. Huber, D. Rosc, and I. Resch Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction Thromb Haemost 60 1988 372 376
14. T. Fujino, J. Katou, and M. Fujita Relationship between serum lipoprotein(a) level and thrombin generation to the circadian variation in onset of acute myocardial infarction Atherosclerosis 155 2001 171 178
15. A. Petralito, R.A. Mangiafico, and S. Gibiino Daily modifications of plasma fibrinogen platelets aggregation, Howell's time, PTT, TT, and antithrombin II in normal subjects and in patients with vascular disease Chronobiologia 9 1982 195 201
16. A.M. Ehrly, and G. Jung Circadian rhythm of human blood viscosity Biorheology 10 1973 577 583
17. P. Angleton, W.L. Chandler, and G. Schmer Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1) Circulation 79 1989 101 106
18. M.B. Turton, and T. Deegan Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects Clin Chim Acta 55 1974 389 397
19. J.P. Henriques, A.P. Haasdijk, and F. Zijlstra Zwolle myocardial infarction study outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours. Group J Am Coll Cardiol 41 2003 2138 2142
20. A. van t' Hof, A. Liem, and H. Suryapranata Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial blush grade Circulation 97 1998 2302 2306
21. N.M. Ernst, H. Suryapranata, and K. Miedema Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction J Am Coll Cardiol 44 2004 1187 1193
22. M. Fujita, E. Araie, and K. Yamanishi Circadian variation in the success rate of intracoronary thrombolysis for acute myocardial infarction Am J Cardiol 71 1993 1369 1371
23. P.B. Kurnik Circadian variation in the efficacy of tissue-type plasminogen activator Circulation 91 1995 1341 1346
24. K.J. Mukamal, J.E. Muller, and M. Maclure Increased risk of congestive heart failure among infarctions with nighttime onset Am Heart J 140 2000 438 442
25. R.J. Goldberg, J. Yarzebski, and D. Lessard Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack Study Arch Intern Med 160 2000 3217 3223
26. R. Zahn, R. Schiele, and K. Seidl Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group Am Heart J 138 1999 1111 1117
27. G. De Luca, H. Suryapranata, and J.P. Ottervanger Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts Circulation 109 2004 1223 1225
28. G. De Luca, A.W.J. van't Hof, and M.J. de Boer Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty Eur Heart J 12 2004 1009 1013
29. B.G. Angeja, C.M. Gibson, and R. Chin Predictors of door-to-balloon delay in primary angioplasty Am J Cardiol 89 2002 1156 1161
30. F. Zijlstra, and M.J. de Boer Primary angioplasty for acute myocardial infarction: the Zwolle approach Semin Interv Cardiol 41 1999 55 58
31. P. Garot, J.M. Juliard, and H. Benamer Are the results of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction different during the "off" hours? Am J Cardiol 79 1997 1527 1529
32. M. Fujita, and D. Franklin Diurnal changes in coronary blood flow in conscious dogs Circulation 76 1987 488 491
33. E.D. Weitzman, D. Fukushima, and C. Nogeire Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects J Clin Endocrinol Metab 33 1971 14 22
34. J.P. Henriques, F. Zijlstra, and J.P. Ottervanger Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction Eur Heart J 23 2002 1112 1117
35. T. Sakuma, H. Leong-Poi, and N.G. Fisher Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli J Am Soc Echocardiogr 16 2003 15 21
36. A.S. Petronio, D. Rovai, and G. Musumeci Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty Eur Heart J 24 2003 67 76
37. F.J. Neumann, R. Blasini, and C. Schmitt Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction Circulation 98 1998 2695 2701
38. M. Napodano, G. Pasquetto, and S. Sacca Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction J Am Coll Cardiol 42 2003 1395 1402
39. U. Limbruno, A. Micheli, and M. De Carlo Mechanical prevention of distal embolization during primary angioplasty: safety, feasibility, and impact on myocardial reperfusion Circulation 108 2003 171 176